Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, discusses why biomarker testing rates are low among patients with metastatic colorectal cancer, as well as what changes can be...
Pashtoon Kasi, MD, MS, oncologist, director of colon cancer and liquid biopsy research, Weill Cornell Medicine, discusses why biomarker testing rates are low among patients with metastatic colorectal cancer, as well as what changes can be...
Pashtoon Kasi, MD, MS,...